K. J. Kripalani

824 total citations
25 papers, 700 citations indexed

About

K. J. Kripalani is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K. J. Kripalani has authored 25 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K. J. Kripalani's work include Pharmacogenetics and Drug Metabolism (7 papers), Renin-Angiotensin System Studies (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). K. J. Kripalani is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Renin-Angiotensin System Studies (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). K. J. Kripalani collaborates with scholars based in United States, Germany and Malaysia. K. J. Kripalani's co-authors include Bruce H. Migdalof, Sampat M. Singhvi, Harry J. Brodie, Doris N. McKinstry, David A Willard, Robert A. Vukovich, Eric C. Schreiber, S. M. Singhvi, Michael J. Antonaccio and Shih-Jung Lan and has published in prestigious journals such as Journal of the American Chemical Society, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

K. J. Kripalani

25 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. J. Kripalani United States 14 227 189 150 90 90 25 700
Bruce H. Migdalof United States 17 324 1.4× 270 1.4× 126 0.8× 103 1.1× 87 1.0× 39 1.0k
J. D. Baty United Kingdom 15 241 1.1× 114 0.6× 131 0.9× 89 1.0× 57 0.6× 56 843
D S Hewick United Kingdom 11 140 0.6× 117 0.6× 262 1.7× 79 0.9× 44 0.5× 32 641
James M. Jaffe United States 15 192 0.8× 53 0.3× 187 1.2× 118 1.3× 80 0.9× 46 785
K. Carr United States 11 212 0.9× 117 0.6× 194 1.3× 437 4.9× 108 1.2× 17 1.0k
Peter H. Hinderling United States 19 252 1.1× 187 1.0× 200 1.3× 186 2.1× 55 0.6× 48 1.1k
Chyung S. Cook United States 13 200 0.9× 111 0.6× 171 1.1× 153 1.7× 206 2.3× 29 850
I. Bartošek Italy 17 267 1.2× 105 0.6× 163 1.1× 72 0.8× 50 0.6× 60 896
P J Meffin Australia 24 174 0.8× 371 2.0× 364 2.4× 274 3.0× 59 0.7× 38 1.2k
J. Augustín Germany 19 309 1.4× 274 1.4× 45 0.3× 165 1.8× 316 3.5× 46 1.2k

Countries citing papers authored by K. J. Kripalani

Since Specialization
Citations

This map shows the geographic impact of K. J. Kripalani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. J. Kripalani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. J. Kripalani more than expected).

Fields of papers citing papers by K. J. Kripalani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. J. Kripalani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. J. Kripalani. The network helps show where K. J. Kripalani may publish in the future.

Co-authorship network of co-authors of K. J. Kripalani

This figure shows the co-authorship network connecting the top 25 collaborators of K. J. Kripalani. A scholar is included among the top collaborators of K. J. Kripalani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. J. Kripalani. K. J. Kripalani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iyer, Ramaswamy A., Bimal Malhotra, Sanaullah Khan, et al.. (2003). Comparative Biotransformation of Radiolabeled [14C]Omapatrilat and Stable-labeled [13C2]Omapatrilat after Oral Administration to Rats, Dogs, and Humans. Drug Metabolism and Disposition. 31(1). 67–75. 13 indexed citations
2.
Iyer, Ramaswamy A., James Mitroka, Bimal Malhotra, et al.. (2001). Metabolism of [(14)C]omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans.. PubMed. 29(1). 60–9. 16 indexed citations
3.
Everett, Donald W., Thomas Franz, Theodore J. Chando, et al.. (1999). Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé®) solution in healthy volunteers. Biopharmaceutics & Drug Disposition. 20(6). 301–308. 1 indexed citations
4.
Chando, Theodore J., Donald W. Everett, Nimish N. Vachharajani, et al.. (1998). Biotransformation of irbesartan in man.. PubMed. 26(5). 408–17. 60 indexed citations
5.
Morrison, Richard A., K. J. Kripalani, Anthony M. Marino, et al.. (1997). INTESTINAL ABSORPTION OF CAPTOPRIL AND TWO THIOESTER ANALOGS IN RATS AND DOGS. Biopharmaceutics & Drug Disposition. 18(1). 25–39. 2 indexed citations
6.
Marino, Anthony M., et al.. (1996). Distribution of the Dipeptide Transporter System along the Gastrointestinal Tract of Rats Based on Absorption of a Stable and Specific Probe, SQ-29852. Journal of Pharmaceutical Sciences. 85(3). 282–286. 8 indexed citations
7.
Hui, Ka Kit, et al.. (1991). Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clinical Pharmacology & Therapeutics. 49(4). 457–467. 66 indexed citations
8.
Migdalof, Bruce H., et al.. (1984). Captopril: Pharmacology, Metabolism, and Disposition. Drug Metabolism Reviews. 15(4). 841–869. 90 indexed citations
9.
Kripalani, K. J., S. M. Singhvi, Stephen H. Weinstein, et al.. (1984). Disposition of [14C]aztreonam in rats, dogs, and monkeys. Antimicrobial Agents and Chemotherapy. 26(2). 119–126. 10 indexed citations
10.
Kripalani, K. J., et al.. (1983). Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs. Xenobiotica. 13(12). 701–705. 11 indexed citations
11.
Singhvi, S. M., et al.. (1981). Absorption and Bioavailability of Captopril in Mice and Rats After Administration by Gavage and in the Diet. Journal of Pharmaceutical Sciences. 70(8). 885–888. 20 indexed citations
12.
Migdalof, Bruce H., S. M. Singhvi, & K. J. Kripalani. (1980). Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in Blood. Journal of Liquid Chromatography. 3(6). 857–865. 32 indexed citations
13.
Lan, Shengzong, et al.. (1978). Metabolism of α-Methylfluorene-2-acetic acid (Cicloprofen): Isolation and Identification of Metabolites from Rat Urine. Xenobiotica. 8(2). 121–131. 3 indexed citations
14.
Lan, Shengzong, et al.. (1977). Metabolism of the (+)-, (±)-, and (-)-Enantiomers of α-Methylfluorene-2-acetic Acid (Cicloprofen) in Rats. Xenobiotica. 7(9). 549–560. 10 indexed citations
15.
Kripalani, K. J., et al.. (1976). Stereospecific Inversion ofl-α-Methylfluorene-2-acetic Acid to itsd-Enantiomer in the Dog. Xenobiotica. 6(3). 159–169. 16 indexed citations
16.
Lan, Shengzong, et al.. (1976). Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.. Drug Metabolism and Disposition. 4(4). 330–339. 33 indexed citations
17.
Kripalani, K. J., et al.. (1975). Metabolism of Triamcinolone Acetonide-21 -phosphate in Dogs, Monkeys, and Rats. Journal of Pharmaceutical Sciences. 64(8). 1351–1359. 31 indexed citations
18.
Sugar, Joel, Ronald M. Burde, Alan Sugar, et al.. (1972). Tetrahydrotriamcinolone and triamcinolone. I. Ocular penetration.. PubMed. 11(11). 890–3. 4 indexed citations
19.
Brodie, Harry J., et al.. (1969). Mechanism of estrogen biosynthesis. VI. The stereochemistry of hydrogen elimination at C-2 during aromatization. Journal of the American Chemical Society. 91(5). 1241–1242. 76 indexed citations
20.
Kripalani, K. J., et al.. (1967). Binding of cortisol and its degradation products by human serum albumin. Journal of Pharmaceutical Sciences. 56(6). 687–693. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce H. Migdalof Breakdown of academic impact, for papers by J. D. Baty Breakdown of academic impact, for papers by D S Hewick Breakdown of academic impact, for papers by James M. Jaffe Breakdown of academic impact, for papers by K. Carr Breakdown of academic impact, for papers by Peter H. Hinderling Breakdown of academic impact, for papers by Chyung S. Cook Breakdown of academic impact, for papers by I. Bartošek Breakdown of academic impact, for papers by P J Meffin Breakdown of academic impact, for papers by J. Augustín
Rankless by CCL
2026